Skip to main content
Print Save

MYLAN 7155 MYLAN 7155 (Budesonide (Enteric Coated) 3 mg)

Pill with imprint MYLAN 7155 MYLAN 7155 is Red, Capsule-shape and has been identified as Budesonide (Enteric Coated) 3 mg. It is supplied by Mylan Pharmaceuticals Inc.

Budesonide is used in the treatment of crohn's disease; asthma, maintenance; crohn's disease, acute; inflammatory bowel disease; crohn's disease, maintenance and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 7155 MYLAN 7155

Budesonide (enteric coated) 3 mg MYLAN 7155 MYLAN 7155
Budesonide (enteric coated) 3 mg MYLAN 7155 MYLAN 7155
Budesonide (enteric coated) 3 mg MYLAN 7155 MYLAN 7155

Budesonide (Enteric Coated)

Imprint
MYLAN 7155 MYLAN 7155
Strength
3 mg
Color
Red
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Glucocorticoids, Inhaled corticosteroids
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
acetyltributyl citrate, silicon dioxide, dimethicone, ethylcellulose, FD&C Red No. 40, gelatin, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, sodium hydroxide, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-7155 Mylan Pharmaceuticals Inc.
51079-0020 (Discontinued) UDL Laboratories Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer